Biosafety cabinets are efficient devices used to control contamination in laboratories dealing with infectious agents. These act as a primary barrier for restricting the escape of biological aerosols in the lab environment. The biosafety cabinets are broadly classified in three types —class I cabinets, class II cabinets, and class III cabinets. Specific regulations and guidelines imposed by the medical ruling authorities in each region recommend the use of the appropriate type of cabinets to carry out protocols based on the levels of risk involved. The rising prevalence of infectious diseases and increasing strategic initiatives are bolstering the biosafety cabinet market size. The biosafety cabinet market trend includes the increasing adoption of cell-based and regenerative therapies. Moreover, the market size is likely to grow by 2028 owing to rapid developments in pharmaceutical and biotechnology research.
The biosafety cabinet market is segmented on the basis of products handled, category, type, application, end user, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, Middle East, Africa, and South & Central America. The report offers insights and in-depth analysis of the market, emphasizing parameters such as market trends, technological advancements, and market dynamics, along with the competitive landscape analysis of the leading market players across the world.
Infectious diseases are rapidly increasing across the world. The World Health Organization reported that infectious diseases are likely to cause over 30 million deaths each year. According to a new report by TB facts Org, ~10.6 million people were diagnosed with tuberculosis (TB) in 2021, which has increased by 4.5% from 10.1 million in 2020 globally. Additionally, the ease of international travel has led to an additional layer of complexity in terms of tackling with the infectious diseases. Moreover, changing climatic conditions on a global level have contributed to the prevalence of infectious diseases as it can increase the severity of the infectious diseases. As per United Nations Office for Disaster Risk Reduction (UNDDR), climate change can intensify the infectious diseases encountered by humans on global level by 58%.
Since the 1970s, about 40 infectious diseases have been discovered, including SARS, MERS, Ebola virus disease, chikungunya, avian flu, swine flu, zika virus infection, and most recently, COVID-19. As per CDC, between September 2020 and May 2021, 1,675 of 818,939 respiratory specimens tested by US clinical laboratories were positive for an influenza virus in the US. Antibiotic techniques such as vaccinations against influenza help reduce the illness by 17% and medical visits and hospitalizations by 18% and 19%, respectively. Patient samples are collected to conduct a vast number of experiments and studies for formulating anti-dotes and vaccines to curb infectious diseases. Additionally, appropriate care and management of these samples require a suitable workstation and sanitized environment. These controlled and disinfected environments are mostly possible with the use of biological safety cabinets, which propels the growth of the biosafety cabinet market growth.
Based on end user, the global biosafety cabinet market is segmented into academic centers, biotech and pharmaceutical companies, microbiology centers, research and development centers, hospitals and clinics, diagnostic laboratories, and others. The biotech and pharmaceutical companies segment held the largest market share in 2022 and is anticipated to register the highest CAGR during the forecast period. The biosafety cabinets are required in biotech and pharmaceutical companies to test treatments on human and animal tissues and produce biological-based products. In addition, these companies significantly perform the manipulation and processing of tissues, which requires high protection. Moreover, producing vaccines and preparing medicines that use pharmaceutical chemicals requires high sterility. Thus, biosafety cabinets are necessary for pharmaceutical and biotech companies. The development of cell-based therapies is at the forefront among various research and development departments of biotechnology companies. The culturing and assay conduction are critical tasks performed by the personnel in these companies that require an appropriately safe and well-equipped workstation offered by the biosafety cabinets. Thus, the increasing number of research studies in pharmaceutical and biotechnology companies is likely to fuel the growth of the biosafety cabinet market during the forecast period.
Companies are investing in the development of new and innovative instruments to secure good return on investment (ROI). Additionally, the product approval by regulatory authorities confirms the reliability and credibility of new age control units and sanitized workstations. Recently, various market players have launched high-end and top-quality biosafety cabinets and adopted acquisition strategy. A few strategies by market players are listed below:
These recent developments enhance the mode of performing experiments in large and medium-sized laboratories that work with cell cultures. The mounting number of novel product launches and acquisitions facilitates the growth of the biosafety cabinet market.
The regional trends and factors influencing the Biosafety Cabinet Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Biosafety Cabinet Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 276.88 Million |
| Market Size by 2028 | US$ 429.47 Million |
| Global CAGR (2022 - 2028) | 7.6% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Products Handled
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Biosafety Cabinet Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Biosafety Cabinet Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The global biosafety cabinet market is segmented on the basis of products handled, category, type, application, and end user. Based on products handled, the market is bifurcated into biological products and toxic products. Based on category, the market is segmented into work trays, side panel construction, and accessories. Based on type, the market is segmented into class I biosafety cabinet, class II type A2 and class II type B1, class II type B2 biosafety cabinet, class II biosafety cabinet, customized cabinets, and others. Based on application, the global biosafety cabinet market is segmented into medical health, disease prevention, food safety, biological pharmacy, environment monitoring, and others. Based on end user, the market is segmented into academic centers, biotech and pharmaceutical companies, microbiology centers, research and development centers, hospitals and clinics, diagnostic laboratories, and others.
Based on geography, the biosafety cabinet market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East (the UAE, Saudi Arabia, Kuwait, Egypt, and the Rest of Middle East), Africa (South Africa, Nigeria, Kenya, and the Rest of Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Based on type, the class II type A2 and class II type B1 segment held the largest market share of the biosafety cabinet market in 2022 and is anticipated to register the highest CAGR during the forecast period.
Based on end user, the biotech and pharmaceutical companies segment held the largest share of the market in 2022 and is anticipated to register the highest CAGR in the market during the forecast period.
Nuaire Inc, Labconco Corp, Esco Group of Companies, Biobase Biodusty Co Ltd, Thermo Fisher Scientific Inc., IMSET, Heal Force Bio-Meditech Holdings Ltd, Kewaunee Scientific Corp, ACMAS Technologies, Haier Biomedical among others are among the leading companies operating in the biosafety cabinet market.
Global biosafety cabinet market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. North America held the largest market share of the biosafety cabinet market in 2022 and is expected to retain its dominance during the forecast period.
A biosafety cabinet is an enclosed laboratory equipment or workplace that provides a protected environment for laboratory workers and their surroundings. Based on the level of protection for the workforce and the sample, the US Centres of Disease Control and Prevention (CDC) has classified the equipment into three major categories, class I, class II, and class III.
Rising prevalence of infectious diseases and rising strategic initiatives are the key driving factors for the biosafety cabinet market.
Based on the application, the disease prevention segment held the largest market share of the biosafety cabinet market in 2022, and environmental monitoring is anticipated to register the highest CAGR during the forecast period.